Angt Bio

昂拓生物

Angt Bio

Biotech/Healthcare

Angtuo Bio is a biopharmaceutical R&D company building an antisense oligonucleotide-based drug development platform. It develops nucleic acid therapeutics for common metabolic diseases and severe rare diseases, with targets both in and outside the liver.

Latest round: Seed (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-09-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.